000 02153 a2200589 4500
005 20250513234901.0
264 0 _c20010510
008 200105s 0 0 eng d
022 _a0014-2980
024 7 _a10.1002/1521-4141(200104)31:4<1278::aid-immu1278>3.0.co;2-a
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSpahn, T W
245 0 0 _aInduction of oral tolerance to cellular immune responses in the absence of Peyer's patches.
_h[electronic resource]
260 _bEuropean journal of immunology
_cApr 2001
300 _a1278-87 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdministration, Oral
650 0 4 _aAnimals
650 0 4 _aAntibodies
_ximmunology
650 0 4 _aDose-Response Relationship, Immunologic
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aFeces
_xchemistry
650 0 4 _aGene Deletion
650 0 4 _aHypersensitivity, Delayed
_ximmunology
650 0 4 _aImmune Tolerance
_xdrug effects
650 0 4 _aImmunity, Mucosal
_xdrug effects
650 0 4 _aImmunoglobulin A
_ximmunology
650 0 4 _aInterferon-gamma
_xbiosynthesis
650 0 4 _aInterleukin-2
_xmetabolism
650 0 4 _aLymph Nodes
_xabnormalities
650 0 4 _aLymphotoxin-alpha
_xantagonists & inhibitors
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMice, Knockout
650 0 4 _aOvalbumin
_xadministration & dosage
650 0 4 _aPeyer's Patches
_xabnormalities
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aTumor Necrosis Factor-alpha
_xantagonists & inhibitors
700 1 _aFontana, A
700 1 _aFaria, A M
700 1 _aSlavin, A J
700 1 _aEugster, H P
700 1 _aZhang, X
700 1 _aKoni, P A
700 1 _aRuddle, N H
700 1 _aFlavell, R A
700 1 _aRennert, P D
700 1 _aWeiner, H L
773 0 _tEuropean journal of immunology
_gvol. 31
_gno. 4
_gp. 1278-87
856 4 0 _uhttps://doi.org/10.1002/1521-4141(200104)31:4<1278::aid-immu1278>3.0.co;2-a
_zAvailable from publisher's website
999 _c11233385
_d11233385